Relevium Drives Top Line Growth for Q1

Relevium Technologies Inc. is pleased to announce top line growth for Q1 in anticipation of its interim filings.  

Relevium Files and Provides Comments on the Audited Consolidated Financial Statements for the Fiscal Year Ended June 30, 2017 and 2016.

Relevium Technologies Inc. is pleased to announce the filing of the company’s Audited Financial Statements and MD&A for the fiscal year ended June 30, 2017 and 2016 on Sedar.

Relevium Provides Operational Progress Update and Appoints Senior Marketing Officer

Relevium Technologies Inc. is pleased to announce a brief operational update on progress and the appointment of a Senior Marketing Officer.

Relevium Technologies

Relevium is a publicly traded corporation strategically focused on the acquisition of entrepreneurial e-brands and technologies with your health and wellness in mind. Our area of interest and focus include Nutraceuticals, Sports Nutrition and Nutri-cosmeceuticals.


Nutraceuticals are a combination of nutrients and pharmaceutical grade ingredients and include dietary supplements, functional foods and herbs often concentrated in liquid, capsule, powder or pill form. Dietary supplements are regulated by the FDA as foods yet their regulation differs from drugs and other foods. The global nutraceutical market is estimated to be over USD$200 billion now, and to reach USD$300 billion by the end of 2023.

Sports Nutrition

Sports Nutrition is the science which aims to improve fitness and performance. Supplements such as pre-workouts, intra-workouts, proteins and post workouts are formulated with careful attention to three major categories: Energy, Recovery and Performance. The global sports nutrition market is estimated to be USD$29 billion and is expected to reach USD$45 billion by the end of 2022.


Nutricosmetics (ingestible) and Cosmeceuticals (topical) are the combination of natural ingredients, cosmetics and pharmaceutical grade ingredients aimed at improving skin health, as well as, overall health and wellness. The global cosmeceuticals market is estimated to be USD$42 billion and is expected to reach USD$69 billion by 2022.

Subscribe to our Newsletter

You have Successfully Subscribed!